Year: 2022
Type: review
Abstract: Over the last few years, the number of research publications about the role of catecholamines (epinephrine, norepinephrine, and dopamine) in the development of liver diseases such as liver fibrosis, fatty liver diseases, or liver cancers is constantly increasing. However, the mechanisms involved in these effects are not well understood. In this review, we first recapitulate the way the liver is in contact with catecholamines and consider liver implications in their metabolism. A focus on the expression of the adrenergic and dopaminergic receptors by the liver cells is also discussed. Involvement of catecholamines in physiological (glucose metabolism, lipids metabolism, and liver regeneration) and pathophysiological (impact on drug-metabolizing enzymes expression, liver dysfunction during sepsis, fibrosis development, or liver fatty diseases and liver cancers) processes are then discussed. This review highlights the importance of understanding the mechanisms through which catecholamines influence liver functions in order to draw benefit from the adrenergic and dopaminergic antagonists currently marketed. Indeed, as these molecules are well-known drugs, their use as therapies or adjuvant treatments in several liver diseases could be facilitated.
Source: Cells
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Keywords: catecholamines, epinephrine, norepinephrine, dopamine, liver disease, liver fibrosis, hepatic steatosis, liver cancer, adrenergic receptors, dopamine receptors, drug-metabolizing enzymes, glucose metabolism, lipid metabolism, liver regeneration, sepsis, adrenergic antagonists, dopamine antagonists
Open Access status: gold
Estimated APC paid: $1,925
OpenAlex ID: W4221064100
